More SEC Filings
View Older Stories View Newer Stories-
Form DEF 14A SIFCO INDUSTRIES INC For: Sep 30
-
Form FWP BANK OF AMERICA CORP Filed by: BANK OF AMERICA CORP /DE/
-
Form 6-K Achilles Therapeutics For: Dec 26
-
Form 10-K/A Quanterix Corp For: Dec 31
-
Form 20-F noco-noco Inc. For: Jun 30
-
Form 424B2 JPMORGAN CHASE & CO
-
Form S-1/A TEN Holdings, Inc.
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 10-K Bridgeline Digital, Inc. For: Sep 30
-
Form 8-K NEWS CORP For: Dec 23
-
Form 4 Prelude Therapeutics For: Dec 20 Filed by: Combs Andrew
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 8-K Federal Home Loan Bank For: Dec 18
-
Form 10-Q/A Quanterix Corp For: Jun 30
-
Form 8-K Hi-Great Group Holding For: Dec 12
-
Form 6-K TORONTO DOMINION BANK For: Dec 23
-
Form 424B2 JPMORGAN CHASE & CO
-
Form F-4/A GCL Global Holdings Ltd
-
Form D Celero Communications,
-
Form 424B2 BANK OF NOVA SCOTIA
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form 424B2 CITIGROUP INC
-
Form 8-K LandBridge Co LLC For: Dec 19
-
Form 424B2 BARCLAYS BANK PLC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K/A Stardust Power Inc. For: Dec 12
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D INVEXT 280 EARTH A SERIE
-
Form 424B4 MGO Global Inc.
-
Form 424B2 BofA Finance LLC
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 3 374Water Inc. For: Dec 16 Filed by: Russell Kline
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B3 TORONTO DOMINION BANK
-
Form 485BPOS MORGAN STANLEY PATHWAY
-
Form 4 N2OFF, Inc. For: Dec 23 Filed by: Arbib Eliahou
-
Form 4 N2OFF, Inc. For: Dec 23 Filed by: Sidi Liat
-
Form 6-K Borr Drilling Ltd For: Dec 23
-
Form 424B3 TITAN INTERNATIONAL INC
-
Form 10-K SIFCO INDUSTRIES INC For: Sep 30
-
Form 6-K Greenfire Resources Ltd. For: Dec 26
-
Form 4 N2OFF, Inc. For: Dec 23 Filed by: Berenstein Israel Yakov
-
Form 8-K Kennedy-Wilson Holdings, For: Dec 23
-
Form 4 Nuvectis Pharma, Inc. For: Dec 24 Filed by: BENTSUR RON
-
Form 8-K Serina Therapeutics, For: Dec 23
-
Form 424B2 UBS AG


